Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesCTPET/CT identifies bone demineralization in breast cancer patientsPET/CT holds promise as an opportunistic osteoporosis screening tool in high-risk oncology subgroups.MRIIs MRI in patients with retained metal fragments dangerous?Womens ImagingAI shows promise as second reader in breast cancer screeningResidents/FellowsRad residents show interest in global health imaging, but face barriersAIInvestigators test ChatGPT-4 Turbo for radiology AI monitoring
